FIELD: medicine, endocrinology, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition used for treatment of diabetes mellitus and comprising metformin as an active substance and the following accessory substances by variant I: sorbitol, calcium phosphate dihydrate, polyvinylpyrrolidone, polyethylene glycol and stearic acid or its salts and, optionally, starch, and by variant II the following substances are used as special additives: sugar, starch, stearic acid or its salts. Compositions comprise an active substance in doses that is suitable in applying in the medicinal practice.
EFFECT: valuable properties of composition.
13 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
SOLID DOSED FORMULATION FOR TREATMENT OF PANCREATIC DIABETES | 2006 |
|
RU2333760C2 |
SOLID UNIT DOSAGE FORM FOR PANCREATIC DIABETES | 2009 |
|
RU2380097C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES (VERSIONS) | 2010 |
|
RU2483717C2 |
PHARMACEUTICAL COMPOSITION WITH CARDIOSELECTIVE BETA-ADRENERGIC ANTAGONIST (VARIANTS) | 2004 |
|
RU2256447C1 |
ANTIHISTAMINE PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2264814C2 |
PHARMACEUTICAL ANTI-DIABETIC COMPOSITION OF PROLONGED ACTION | 2011 |
|
RU2465896C2 |
ANTITUBERCULAR PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2248797C1 |
METHOD FOR PRODUCING COMPOSITION AND COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY | 2001 |
|
RU2182825C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
Authors
Dates
2004-12-10—Published
2003-09-25—Filed